Protect TUDCA stimulated CKD-derived hMSCs against the CKD-Ischemic disease via upregulation of PrPC
Yeo Min Yoon, SangMin Kim, Yong-Seok Han, Chul Won Yun, Jun Hee Lee, Hyunjin Noh, Sang Hun Lee
This study shows TUDCA treatment improves mitochondrial function and PrPC expression in CKD-derived hMSCs, enhancing their therapeutic potential in CKD-ischemic disease.
bioRxiv · Aug 27, 2018 · PreprintCell Biology